Log in

Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Abstract

Depression during the first year postpartum (postpartum depression) impacts millions of women and their families worldwide. In this narrative review, we provide a summary of postpartum depression, examining the etiology and consequences, pharmacological and psychological treatments, and potential mechanisms of change and current barriers to care. Psychological treatments are effective and preferred by many perinatal patients over medications, but they often remain inaccessible. Key potential mechanisms underlying their effectiveness include treatment variables (e.g., dosage and therapeutic alliance) and patient behaviors (e.g., activation and avoidance and emotional regulation). Among pharmacological treatments, the selective serotonin reuptake inhibitor (SSRI) sertraline is generally the first-line antidepressant medication recommended to women in the postpartum period due to its minimal passage into breastmilk and the corresponding decades of safety data. Importantly, most antidepressant drugs are considered compatible with breastfeeding. Neurosteroids are emerging as an effective treatment for postpartum depression, although currently this treatment is not widely available. Barriers to widespread access to treatment include those that are systematic (e.g., lack of specialist providers), provider-driven (e.g., lack of flexibility in treatment delivery), and patient-driven (e.g., stigma and lack of time for treatment engagement). We propose virtual care, task-sharing to non-specialist treatment providers, and collaborative care models as potential solutions to enhance the reach and scalability of effective treatments to address the growing burden of postpartum depression worldwide and its negative impact on families and society.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Shorey S, Chee CYI, Ng ED, Chan YH, Tam WWS, Chong YS. Prevalence and incidence of postpartum depression among healthy mothers: a systematic review and meta-analysis. J Psychiatr Res. 2018;104:235–48.

    Article  PubMed  Google Scholar 

  2. Falah-Hassani K, Shiri R, Dennis CL. The prevalence of antenatal and postnatal co-morbid anxiety and depression: a meta-analysis. Psychol Med. 2017;47(12):2041–53.

    Article  CAS  PubMed  Google Scholar 

  3. Gelaye B, Rondon MB, Araya R, Williams MA. Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countries. Lancet Psychiatry. 2016;3(10):973–82.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Evins GG, Theofrastous JP, Galvin SL. Postpartum depression: a comparison of screening and routine clinical evaluation. Am J Obstet Gynecol. 2000;182(5):1080–2.

    Article  CAS  PubMed  Google Scholar 

  5. Whitton A, Appleby L, Warner R. Maternal thinking and the treatment of postnatal depression. Int Rev Psychiatry. 1996;8(1):73–8.

    Article  Google Scholar 

  6. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Interventions to prevent perinatal depression: US Preventive Services Task Force recommendation statement. JAMA. 2019;321(6):580–7.

    Article  PubMed  Google Scholar 

  7. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 2010;303(19):1961–9.

    Article  CAS  PubMed  Google Scholar 

  8. Borges G, Bagge CL, Orozco R. A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord. 2016;195:63–74.

    Article  PubMed  Google Scholar 

  9. Dennis CL, Marini F, Dol J, Vigod SN, Grigoriadis S, Brown HK. Paternal prevalence and risk factors for comorbid depression and anxiety across the first 2 years postpartum: a nationwide Canadian cohort study. Depress Anxiety. 2022;39(3):233–45.

    Article  PubMed  Google Scholar 

  10. Goodman JH. Paternal postpartum depression, its relationship to maternal postpartum depression, and implications for family health. J Adv Nurs. 2004;45(1):26–35.

    Article  PubMed  Google Scholar 

  11. Soliday E, McCluskey-Fawcett K, O’Brien M. Postpartum affect and depressive symptoms in mothers and fathers. Am J Orthopsychiatry. 1999;69(1):30–8.

    Article  CAS  PubMed  Google Scholar 

  12. Goodman J. Influences of maternal postpartum depression on fathers and on father-infant interactions. Infant Ment Health J. 2008;29:624–43.

    Article  PubMed  Google Scholar 

  13. Slomian J, Honvo G, Emonts P, Reginster JY, Bruyère O. Consequences of maternal postpartum depression: a systematic review of maternal and infant outcomes. Womens Health (Lond). 2019;15:1745506519844044.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Couto TC, Brancaglion MY, Alvim-Soares A, Moreira L, Garcia FD, Nicolato R, et al. Postpartum depression: a systematic review of the genetics involved. World J Psychiatry. 2015;5(1):103–11.

    Article  PubMed  PubMed Central  Google Scholar 

  15. O’Hara MW, Mccabe JE. Postpartum depression: current status and future directions. Ann Rev Clin Psychol. 2013;9(1):379–407.

    Article  Google Scholar 

  16. Henshaw C. Mood disturbance in the early puerperium: a review. Arch Womens Ment Health. 2003;6(Suppl 2):S33-42.

    Article  PubMed  Google Scholar 

  17. Forty L, Jones L, Macgregor S, Caesar S, Cooper C, Hough A, et al. Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry. 2006;163(9):1549–53.

    Article  PubMed  Google Scholar 

  18. Treloar SA, Martin NG, Bucholz KK, Madden PAF, Heath AC. Genetic influences on post-natal depressive symptoms: findings from an Australian twin sample. Psychol Med. 1999;29(3):645–54.

    Article  CAS  PubMed  Google Scholar 

  19. Silberstein M, Nesbit N, Cai J, Lee PH. Pathway analysis for genome-wide genetic variation data: analytic principles, latest developments, and new opportunities. J Genet Genom. 2021;48(3):173–83.

    Article  Google Scholar 

  20. Comasco E, Sylvén SM, Papadopoulos FC, Sundström-Poromaa I, Oreland L, Skalkidou A. Postpartum depression symptoms: a case-control study on monoaminergic functional polymorphisms and environmental stressors. Psychiatr Genet. 2011;21(1):19–28.

    Article  PubMed  Google Scholar 

  21. Mitchell C, Notterman D, Brooks-Gunn J, Hobcraft J, Garfinkel I, Jaeger K, et al. Role of mother’s genes and environment in postpartum depression. Proc Natl Acad Sci USA. 2011;108(20):8189–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Payne JL, Maguire J. Pathophysiological mechanisms implicated in postpartum depression. Front Neuroendocrinol. 2019;52:165–80.

    Article  CAS  PubMed  Google Scholar 

  23. Lindahl V, Pearson JL, Colpe L. Prevalence of suicidality during pregnancy and the postpartum. Arch Womens Ment Health. 2005;8(2):77–87.

    Article  CAS  PubMed  Google Scholar 

  24. Tabb KM, Dalton VK, Tilea A, Kolenic GE, Admon LK, Hall SV, et al. Trends in antenatal depression and suicidal ideation diagnoses among commercially insured childbearing individuals in the United States, 2008–2018. J Affect Disord. 2023;01(320):263–7.

    Article  Google Scholar 

  25. Meyer CL, Oberman M. Mothers who kill their children: understanding the acts of moms from Susan Smith to the “Prom mom.” New York: New York University Press; 2001.

    Google Scholar 

  26. Jennings KD, Ross S, Popper S, Elmore M. Thoughts of harming infants in depressed and nondepressed mothers. J Affect Disord. 1999;54(1–2):21–8.

    Article  CAS  PubMed  Google Scholar 

  27. Da Costa D, Dritsa M, Rippen N, Lowensteyn I, Khalifé S. Health-related quality of life in postpartum depressed women. Arch Womens Ment Health. 2006;9(2):95–102.

    Article  PubMed  Google Scholar 

  28. Darcy JM, Grzywacz JG, Stephens RL, Leng I, Clinch CR, Arcury TA. Maternal depressive symptomatology: 16-month follow-up of infant and maternal health-related quality of life. J Am Board Fam Med. 2011;24(3):249–57.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Dennis CL, McQueen K. The relationship between infant-feeding outcomes and postpartum depression: a qualitative systematic review. Pediatrics. 2009;123(4):e736–51.

    Article  PubMed  Google Scholar 

  30. Stein A, Pearson RM, Goodman SH, Rapa E, Rahman A, McCallum M, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800–19.

    Article  PubMed  Google Scholar 

  31. Goodman SH, Gotlib IH. Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev. 1999;106(3):458–90.

    Article  CAS  PubMed  Google Scholar 

  32. Sameroff A, Seifer R, Zax M, Barocas R. Early indicators of developmental risk: Rochester longitudinal study. Schizophr Bull. 1987;13(3):383–94.

    Article  CAS  PubMed  Google Scholar 

  33. Cox AD, Puckering C, Pound A, Mills M. The impact of maternal depression in young children. J Child Psychol Psychiatry. 1987;28(6):917–28.

    Article  CAS  PubMed  Google Scholar 

  34. Lyons-Ruth K, Alpern L, Repacholi B. Disorganized infant attachment classification and maternal psychosocial problems as predictors of hostile-aggressive behavior in the preschool classroom. Child Dev. 1993;64(2):572–85.

    Article  CAS  PubMed  Google Scholar 

  35. Stein A, Gath DH, Bucher J, Bond A, Day A, Cooper PJ. The relationship between post-natal depression and mother-child interaction. Br J Psychiatry. 1991;158:46–52.

    Article  CAS  PubMed  Google Scholar 

  36. Bauer A, Parsonage M, Knapp M, Iemmi V, Adelaja B. The costs of perinatal mental health problems. Personal Social Services Research Unit Centre for Mental Health Maternal Mental Health Alliance; 2014. https://eprints.lse.ac.uk/59885/.

  37. Sarris J, O’Neil A, Coulson CE, Schweitzer I, Berk M. Lifestyle medicine for depression. BMC Psychiatry. 2014;14(1):107.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Sigurdsson E, Olafsdottir T, Gottfredsson M. Public views on antidepressant treatment: lessons from a national survey. Laeknabladid. 2009;95(12):837–41.

    PubMed  Google Scholar 

  39. Physical activity and exercise during pregnancy and the postpartum period: ACOG Committee Opinion, Number 804. Obstet Gynecol. 2020;135(4):e178–e88.

  40. Morres ID, Tzouma NA, Hatzigeorgiadis A, Krommidas C, Kotronis KV, Dafopoulos K, et al. Exercise for perinatal depressive symptoms: a systematic review and meta-analysis of randomized controlled trials in perinatal health services. J Affect Disord. 2022;298(Pt A):26–42.

    Article  PubMed  Google Scholar 

  41. Ribeiro MM, Andrade A, Nunes I. Physical exercise in pregnancy: benefits, risks and prescription. J Perinat Med. 2022;50(1):4–17.

    Article  CAS  PubMed  Google Scholar 

  42. La Forge RMS. Aligning mind and body: exploring the disciplines of mindful exercise. ACSM’s Health Fit J. 2005;9(5):7.

    Article  Google Scholar 

  43. Quirk SE, Williams LJ, O’Neil A, Pasco JA, Jacka FN, Housden S, et al. The association between diet quality, dietary patterns and depression in adults: a systematic review. BMC Psychiatry. 2013;13(1):175.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Jacka FN, Cherbuin N, Anstey KJ, Butterworth P. Does reverse causality explain the relationship between diet and depression? J Affect Disord. 2015;01(175):248–50.

    Article  Google Scholar 

  45. Sun Y, Ferguson M, Reeves MM, Kelly JT. Maternal dietary patterns and risk of postpartum depression: a systematic review. Matern Child Health J. 2023;27(12):2077–90.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Tsai Z, Shah N, Tahir U, Mortaji N, Owais S, Perreault M, et al. Dietary interventions for perinatal depression and anxiety: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2023;117(6):1130–42.

    Article  CAS  PubMed  Google Scholar 

  47. Dennis C-L. Peer support within a health care context: a concept analysis. Int J Nurs Stud. 2003;40(3):321–32.

    Article  PubMed  Google Scholar 

  48. Dennis C-L, Hodnett E, Kenton L, Weston J, Zupancic J, Stewart DE, et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. BMJ. 2009;338: a3064.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Feinberg ME. The internal structure and ecological context of coparenting: a framework for research and intervention. Parenting. 2003;3(2):95–131.

    Article  PubMed  Google Scholar 

  50. **ao X, Loke AY. The effects of co-parenting/intergenerational co-parenting interventions during the postpartum period: a systematic review. Int J Nurs Stud. 2021;119:103951.

    Article  PubMed  Google Scholar 

  51. Sockol LE. A systematic review of the efficacy of cognitive behavioral therapy for treating and preventing perinatal depression. J Affect Disord. 2015;177:7–21.

    Article  PubMed  Google Scholar 

  52. Dennis C-L, Creedy D. Psychosocial and psychological interventions for preventing postpartum depression. Cochrane Database Syst Rev. 2004. https://doi.org/10.1002/14651858.CD001134.pub2.

    Article  PubMed  Google Scholar 

  53. O’Connor E, Senger CA, Henninger ML, Coppola E, Gaynes BN. Interventions to prevent perinatal depression: evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2019;321(6):588–601.

    Article  PubMed  Google Scholar 

  54. Singla DR, Savel K, Dennis C-L, Kim J, Silver RK, Vigod S, et al. Scaling up mental healthcare for perinatal populations: is telemedicine the answer? Curr Psychiatry Rep. 2022;24:881–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Singla DR, Lawson A, Kohrt BA, Jung JW, Meng Z, Ratjen C, et al. Implementation and effectiveness of nonspecialist-delivered interventions for perinatal mental health in high-income countries: a systematic review and meta-analysis. JAMA Psychiat. 2021;78(5):498–509.

    Article  Google Scholar 

  56. Kazdin AE. Addressing the treatment gap: a key challenge for extending evidence-based psychosocial interventions. Behav Res Ther. 2017;88:7–18.

    Article  PubMed  Google Scholar 

  57. Hafeman DM, Schwartz S. Opening the black box: a motivation for the assessment of mediation. Int J Epidemiol. 2009;38(3):838–45.

    Article  PubMed  Google Scholar 

  58. Kraemer HC. Messages for clinicians: moderators and mediators of treatment outcome in randomized clinical trials. Am J Psychiatry. 2016;173(7):672–9.

    Article  PubMed  Google Scholar 

  59. Magill M, Kiluk BD, McCrady BS, Tonigan JS, Longabaugh R. Active ingredients of treatment and client mechanisms of change in behavioral treatments for alcohol use disorders: progress 10 years later. Alcohol Clin Exp Res. 2015;39(10):1852–62.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Tissera H, Auger E, Séguin L, Kramer MS, Lydon JE. Happy prenatal relationships, healthy postpartum mothers: a prospective study of relationship satisfaction, postpartum stress, and health. Psychol Health. 2021;36(4):461–77.

    Article  PubMed  Google Scholar 

  61. Hagaman A, LeMasters K, Zivich PN, Sikander S, Bates LM, Bhalotra S, et al. Longitudinal effects of perinatal social support on maternal depression: a marginal structural modelling approach. J Epidemiol Community Health. 2021;75(10):936–43.

    Article  PubMed  Google Scholar 

  62. Singla DR, MacKinnon DP, Fuhr DC, Sikander S, Rahman A, Patel V. Multiple mediation analysis of the peer-delivered Thinking Healthy Programme for perinatal depression: findings from two parallel, randomised controlled trials. Br J Psychiatry. 2021;218(3):143–50.

    Article  PubMed  Google Scholar 

  63. Singla DR, Kumbakumba E, Aboud FE. Effects of a parenting intervention to address maternal psychological wellbeing and child development and growth in rural Uganda: a community-based, cluster randomised trial. Lancet Glob Health. 2015;3(8):e458–69.

    Article  PubMed  Google Scholar 

  64. McDonald S, Kehler H, Bayrampour H, Fraser-Lee N, Tough S. Risk and protective factors in early child development: results from the All Our Babies (AOB) pregnancy cohort. Res Dev Disabil. 2016;58:20–30.

    Article  PubMed  Google Scholar 

  65. Dimidjian S, Goodman SH, Sherwood NE, Simon GE, Ludman E, Gallop R, et al. A pragmatic randomized clinical trial of behavioral activation for depressed pregnant women. J Consult Clin Psychol. 2017;85(1):26.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Cooper AA, Clifton EG, Feeny NC. An empirical review of potential mediators and mechanisms of prolonged exposure therapy. Clin Psychol Rev. 2017;56:106–21.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Gros DF, Price M, Strachan M, Yuen EK, Milanak ME, Acierno R. Behavioral activation and therapeutic exposure: an investigation of relative symptom changes in PTSD and depression during the course of integrated behavioral activation, situational exposure, and imaginal exposure techniques. Behav Modif. 2012;36(4):580–99.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Wilhelm FH, Pfaltz MC, Gross JJ, Mauss IB, Kim SI, Wiederhold BK. Mechanisms of virtual reality exposure therapy: the role of the behavioral activation and behavioral inhibition systems. Appl Psychophysiol Biofeedback. 2005;30(3):271–84.

    Article  PubMed  Google Scholar 

  69. Goldstein BL, Briggs-Gowan MJ, Greene CC, Chang R, Grasso DJ. An item response theory examination of the original and short forms of the Difficulties in Emotion Regulation Scale (DERS) in pregnant women. J Clin Psychol. 2021;77(7):1591–606.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Howard LM, Megnin-Viggars O, Symington I, Pilling S, Guideline DG. Antenatal and postnatal mental health: summary of updated NICE guidance. BMJ. 2014;18(349): g7394.

    Article  Google Scholar 

  71. Vigod SN, Stewart DE. Postpartum depression. N Engl J Med. 2017;376(9):895.

    Article  PubMed  Google Scholar 

  72. Meltzer-Brody S, Colquhoun H, Riesenberg R, Epperson CN, Deligiannidis KM, Rubinow DR, et al. Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet. 2018;392(10152):1058–70.

    Article  CAS  PubMed  Google Scholar 

  73. Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017;390(10093):480–9.

    Article  CAS  PubMed  Google Scholar 

  74. Kanes SJ, Colquhoun H, Doherty J, Raines S, Hoffmann E, Rubinow DR, et al. Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression. Hum Psychopharmacol. 2017;32(2):e2576.

    Article  PubMed  PubMed Central  Google Scholar 

  75. FDA approves first oral treatment for postpartum depression. 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-first-oral-treatment-postpartum-depression. Accessed 09 Aug 2023.

  76. Konstantinou GN, Vigod SN, Mehta S, Daskalakis ZJ, Blumberger DM. A systematic review of non-invasive neurostimulation for the treatment of depression during pregnancy. J Affect Disord. 2020;01(272):259–68.

    Article  Google Scholar 

  77. Gressier F, Rotenberg S, Cazas O, Hardy P. Postpartum electroconvulsive therapy: a systematic review and case report. Gen Hosp Psychiatry. 2015;37(4):310–4.

    Article  PubMed  Google Scholar 

  78. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540–60.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Brown JVE, Wilson CA, Ayre K, Robertson L, South E, Molyneaux E, et al. Antidepressant treatment for postnatal depression. Cochrane Database Syst Rev. 2021;2(2):CD013560.

    PubMed  Google Scholar 

  80. Schoretsanitis G, Westin AA, Stingl JC, Deligiannidis KM, Paulzen M, Spigset O. Antidepressant transfer into amniotic fluid, umbilical cord blood & breast milk: a systematic review & combined analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;20(107): 110228.

    Article  Google Scholar 

  81. Weissman AM, Levy BT, Hartz AJ, Bentler S, Donohue M, Ellingrod VL, et al. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry. 2004;161(6):1066–78.

    Article  PubMed  Google Scholar 

  82. Orsolini L, Bellantuono C. Serotonin reuptake inhibitors and breastfeeding: a systematic review. Hum Psychopharmacol Clin Exp. 2015;30(1):4–20.

    Article  CAS  Google Scholar 

  83. Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, et al. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014;370(25):2397–407.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Sriraman NK, Melvin K, Meltzer-Brody S. ABM Clinical Protocol #18: use of antidepressants in breastfeeding mothers. Breastfeed Med. 2015;10(6):290–9.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Smit M, Dolman KM, Honig A. Mirtazapine in pregnancy and lactation—a systematic review. Eur Neuropsychopharmacol. 2016;26(1):126–35.

    Article  CAS  PubMed  Google Scholar 

  86. Drugs and Lactation Database (LactMed®). 2006.

  87. Gentile S. Tricyclic antidepressants in pregnancy and puerperium. Expert Opin Drug Saf. 2014;13(2):207–25.

    Article  CAS  PubMed  Google Scholar 

  88. Sharma V, Sommerdyk C, **e B. Aripiprazole augmentation of antidepressants for postpartum depression: a preliminary report. Arch Womens Ment Health. 2015;18(1):131–4.

    Article  PubMed  Google Scholar 

  89. Kittel-Schneider S, Felice E, Buhagiar R, Lambregtse-van den Berg M, Wilson CA, Banjac Baljak V, et al. Treatment of peripartum depression with antidepressants and other psychotropic medications: a synthesis of clinical practice guidelines in Europe. Int J Environ Res Public Health. 2022;19(4):1973.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Misri S, Corral M, Wardrop AA, Kendrick K. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol. 2006;26(5):508–11.

    Article  PubMed  Google Scholar 

  91. Lee A, Giesbrecht E, Dunn E, Ito S. Excretion of quetiapine in breast milk. Am J Psychiatry. 2004;161:1715–6.

    Article  PubMed  Google Scholar 

  92. Uguz F. A new safety scoring system for the use of psychotropic drugs during lactation. Am J Ther. 2021;28(1):e118–26.

    Article  PubMed  Google Scholar 

  93. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics. 2009;124(4):e547–56.

    Article  PubMed  Google Scholar 

  94. Olanzapine. 2022. https://www.ncbi.nlm.nih.gov/sites/books/NBK501056/. Accessed 11 July 2023.

  95. Gilad O, Merlob P, Stahl B, Klinger G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6(2):55–8.

    Article  PubMed  Google Scholar 

  96. Hale T. Medications and mothers’ milk. Amarillo: Hale Publishing; 2014.

    Google Scholar 

  97. Howard LM, Molyneaux E, Dennis CL, Rochat T, Stein A, Milgrom J. Non-psychotic mental disorders in the perinatal period. Lancet. 2014;384(9956):1775–88.

    Article  PubMed  Google Scholar 

  98. Kelly LE, Poon S, Madadi P, Koren G. Neonatal benzodiazepines exposure during breastfeeding. J Pediatr. 2012;161(3):448–51.

    Article  CAS  PubMed  Google Scholar 

  99. Kohen D. Psychotropic medication and breast-feeding. Adv Psychiatr Treat. 2005;11(5):371–9.

    Article  Google Scholar 

  100. Zolpidem. 2023. https://www.ncbi.nlm.nih.gov/books/NBK501265/. Accessed 11 July 2023.

  101. Pregnancy and breastfeeding treatment of psychiatric and substance misuse disorders. CNWL NHS Foundation Trust; 2017. https://www.transformationpartners.nhs.uk/wp-content/uploads/2019/05/Pre-conception-advice-Best-Practice-Toolkit-for-Perinatal-Mental-Health-Services.pdf.

  102. MacKenzie G, Maguire J. The role of ovarian hormone-derived neurosteroids on the regulation of GABAA receptors in affective disorders. Psychopharmacology. 2014;231(17):3333–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Schiller CE, Meltzer-Brody S, Rubinow DR. The role of reproductive hormones in postpartum depression. CNS Spectr. 2015;20(1):48–59.

    Article  PubMed  Google Scholar 

  104. Wald J, Henningsson A, Hanze E, Hoffmann E, Li H, Colquhoun H, et al. Allopregnanolone concentrations in breast milk and plasma from healthy volunteers receiving brexanolone injection, with population pharmacokinetic modeling of potential relative infant dose. Clin Pharmacokinet. 2022;61(9):1307–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Deligiannidis KM, Meltzer-Brody S, Maximos B, Peeper EQ, Freeman M, Lasser R, et al. Zuranolone for the treatment of postpartum depression. Am J Psychiatry. 2023;180:668–75.

    Article  PubMed  Google Scholar 

  106. Byatt N, Simas TAM, Lundquist RS, Johnson JV, Ziedonis DM. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynecol. 2012;33(4):143–61.

    Article  Google Scholar 

  107. Byatt N, Biebel K, Lundquist RS, Moore Simas TA, Debordes-Jackson G, Allison J, et al. Patient, provider, and system-level barriers and facilitators to addressing perinatal depression. J Reprod Infant Psychol. 2012;30(5):436–49.

    Article  Google Scholar 

  108. Hicks LM, Ou C, Charlebois J, Tarasoff L, Pawluski J, Roos LE, et al. Assessment of Canadian perinatal mental health services from the provider perspective: where can we improve? Front Psychiatry. 2022;13: 929496.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Bruckner TA, Scheffler RM, Shen G, Yoon J, Chisholm D, Morris J, et al. The mental health workforce gap in low- and middle-income countries: a needs-based approach. Bull World Health Organ. 2011;89(3):184–94.

    Article  PubMed  Google Scholar 

  110. Bayrampour H, Hapsari AP, Pavlovic J. Barriers to addressing perinatal mental health issues in midwifery settings. Midwifery. 2018;59:47–58.

    Article  PubMed  Google Scholar 

  111. Byatt N, Biebel K, Friedman L, Debordes-Jackson G, Ziedonis D, Pbert L. Patient’s views on depression care in obstetric settings: how do they compare to the views of perinatal health care professionals? Gen Hosp Psychiatry. 2013;35(6):598–604.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Kim JJ, La Porte LM, Corcoran M, Magasi S, Batza J, Silver RK. Barriers to mental health treatment among obstetric patients at risk for depression. Am J Obstet Gynecol. 2010;202(3):312.e1-5.

    Article  PubMed  Google Scholar 

  113. DiBari JN, Yu SM, Chao SM, Lu MC. Use of postpartum care: predictors and barriers. J Pregnancy. 2014;2014: 530769.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Sambrook Smith M, Lawrence V, Sadler E, Easter A. Barriers to accessing mental health services for women with perinatal mental illness: systematic review and meta-synthesis of qualitative studies in the UK. BMJ Open. 2019;9(1): e024803.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Megnin-Viggars O, Symington I, Howard LM, Pilling S. Experience of care for mental health problems in the antenatal or postnatal period for women in the UK: a systematic review and meta-synthesis of qualitative research. Arch Womens Ment Health. 2015;18(6):745–59.

    Article  PubMed  Google Scholar 

  116. Evagorou O, Arvaniti A, Samakouri M. Cross-cultural approach of postpartum depression: manifestation, practices applied, risk factors and therapeutic interventions. Psychiatr Q. 2016;87(1):129–54.

    Article  PubMed  Google Scholar 

  117. Callister LC, Beckstrand RL, Corbett C. Postpartum depression and help-seeking behaviors in immigrant Hispanic women. J Obstet Gynecol Neonatal Nurs. 2011;40(4):440–9.

    Article  PubMed  Google Scholar 

  118. Singla DR, Meltzer-Brody S, Savel K, Silver RK. Scaling up patient-centered psychological treatments for perinatal depression in the wake of a global pandemic. Front Psychiatry. 2022. https://doi.org/10.3389/fpsyt.2021.826019.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Wichman CL, Laszewski A, Doering JJ, Borchardt S. Feasibility of model adaptations and implementation of a perinatal psychiatric teleconsultation program. Gen Hosp Psychiatry. 2019;59:51–7.

    Article  PubMed  Google Scholar 

  120. Dennis C-L, Grigoriadis S, Zupancic J, Kiss A, Ravitz P. Telephone-based nurse-delivered interpersonal psychotherapy for postpartum depression: nationwide randomised controlled trial. Br J Psychiatry. 2020;216(4):189–96.

    Article  PubMed  Google Scholar 

  121. Dennis CL. The effect of peer support on postpartum depression: a pilot randomized controlled trial. Can J Psychiatry. 2003;48(2):115–24.

    Article  PubMed  Google Scholar 

  122. Letourneau N, Stewart M, Dennis CL, Hegadoren K, Duffett-Leger L, Watson B. Effect of home-based peer support on maternal-infant interactions among women with postpartum depression: a randomized, controlled trial. Int J Ment Health Nurs. 2011;20(5):345–57.

    Article  PubMed  Google Scholar 

  123. Vigod SN, Slyfield Cook G, Macdonald K, Hussain-Shamsy N, Brown HK, de Oliveira C, et al. Mother matters: pilot randomized wait-list controlled trial of an online therapist-facilitated discussion board and support group for postpartum depression symptoms. Depress Anxiety. 2021;38(8):816–25.

    Article  PubMed  Google Scholar 

  124. Zhou C, Hu H, Wang C, Zhu Z, Feng G, Xue J, et al. The effectiveness of mHealth interventions on postpartum depression: a systematic review and meta-analysis. J Telemed Telecare. 2022;28(2):83–95.

    Article  PubMed  Google Scholar 

  125. Vigod SN, Dennis CL. Advances in virtual care for perinatal mental disorders. World Psychiatry. 2020;19(3):328–9.

    Article  PubMed  PubMed Central  Google Scholar 

  126. Organization WH. Task shifting: rational redistribution of tasks among health workforce teams: global recommendations and guidelines. 2007.

  127. Singla DR, Lawson A, Kohrt BA, Jung JW, Meng Z, Ratjen C, et al. Implementation and effectiveness of nonspecialist-delivered interventions for perinatal mental health in high-income countries. JAMA Psychiat. 2021;78(5):498.

    Article  Google Scholar 

  128. Fang Q, Lin L, Chen Q, Yuan Y, Wang S, Zhang Y, et al. Effect of peer support intervention on perinatal depression: a meta-analysis. Gen Hosp Psychiatry. 2022;74:78–87.

    Article  PubMed  Google Scholar 

  129. Dennis CL. Psychosocial interventions for the treatment of perinatal depression. Best Pract Res Clin Obstet Gynaecol. 2014;28(1):97–111.

    Article  PubMed  Google Scholar 

  130. Leung SS, Lee AM, Chiang VC, Lam SK, Kuen YW, Wong DF. Culturally sensitive, preventive antenatal group cognitive-behavioural therapy for Chinese women with depression. Int J Nurs Pract. 2013;19(Suppl 1):28–37.

    Article  PubMed  Google Scholar 

  131. Singla DR, Hossain S, Andrejek N, Cohen MJ, Dennis C-L, Kim J, et al. Culturally sensitive psychotherapy for perinatal women: a mixed methods study. J Consult Clin Psychol. 2022;90(10):770–86.

    Article  PubMed  Google Scholar 

  132. Moore Simas TA, Flynn MP, Kroll-Desrosiers AR, Carvalho SM, Levin LL, Biebel K, et al. A systematic review of integrated care interventions addressing perinatal depression care in ambulatory obstetric care settings. Clin Obstet Gynecol. 2018;61(3):573–90.

    Article  PubMed  PubMed Central  Google Scholar 

  133. Pawar D, Huang CC, Wichman C. Co-located perinatal psychiatry clinic: impact of adding a psychologist on clinical quality improvement metrics. J Psychosom Obstet Gynaecol. 2019;40(2):123–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cindy-Lee Dennis.

Ethics declarations

Funding

The other authors have no disclosures.

Conflict of interest

Dr. Vigod receives royalties from UpToDate Inc. for authorship of materials related to depression and pregnancy. Dr. Clark receives consulting fees for Seven Starling as a Mental Health Consultant. Sophie Grigoriadis has received royalties from UpToDate, Compendium of Pharmaceuticals, and IPT to Go outside the submitted work over the last year. The other authors have no disclosures.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author’s contributions

CLD, DRS and SNV drafted the initial version of this manuscript with significant contributions from KS, HKB, CTC, and SG. All authors have critically reviewed this manuscript, have provided consent for publication, and agree to be accountable for the work.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dennis, CL., Singla, D.R., Brown, H.K. et al. Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions. Drugs 84, 645–659 (2024). https://doi.org/10.1007/s40265-024-02038-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40265-024-02038-z

Navigation